Results

1–10 of 122 results for Retinal Disease

Impact of Loss of Good Days Copay Assistance Program on Clinical and Anatomical Outcomes of Retinal Disease
Danny A. Mammo, MD
Updates from the Field
2026
Complications of Transvitreal Subretinal Injections for Gene Therapy Vectors in Inherited Retinal Diseases
Chloe TL Khoo, MD
Annual Meeting Talks
2023
Eighteen-Month Results From the Phase 1b-2 Study of Tinlarebant in Adolescent Subjects with Stargardt Disease
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2023
MCO-010 Optogenetic Therapy for Severe Vision Loss in Stargardt Disease: 6-Month Outcomes From the Phase 2 STARLIGHT Trial
Allen C Ho, MD FASRS
Annual Meeting Talks
2023
North Carolina Macular Dystrophy NCMD-MCDR1- Analysis of Our Entire Database a Model Disease of Noncoding Mutations
Kent W. Small, MD
Annual Meeting Talks
2023
Epidemiology of Inherited Retinal Diseases in the United States- IRIS Registry Intelligent Research In Sight Analysis
Ahmad Al-Moujahed, MD, PhD, MPH
Annual Meeting Talks
2023
Development and Evaluation of an Artificial Intelligence Algorithm for Pediatric Retinal Disease Screening Using Widefield Fundus Photography
Lejla Vajzovic, MD, FASRS
Annual Meeting Talks
2023
Outcomes of Children With Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy
Arjun B Sood, MD
Annual Meeting Talks
2023
Albinotic Fundus
KANWALJEET HARJOT MADAN, M.S. (Ophthalmology) Fellow in Vitreous & Retina
Retina Image Bank: Images of the Week
2025
Oral Gildeuretinol Acetate 14 mg Capsules Stalled Stargardt Disease Progression: Updates in the TEASE-3 Study
Michael Gorin, MD, PhD
Annual Meeting Talks
2024